Srividhya Ragavan, ‘Waive the IP Rights and Save Lives’

In October of 2020, when India and South Africa proposed a waiver from certain provisions of the TRIPS agreement, it was meant to increase local manufacturing capacity in these countries although the waiver, in enabling vaccination of populations across the globe, would be critical to normalize global trade. The waiver was proposed as a tool to kick-start prevention, containment and treatment of COVID-19. While there is an imminent need to meet a growing supply-demand gap for all medical products, COVID-19 related products are urgently required in poorer nations to contain the pandemic. The paper hopes to capture the benefits of the waiver and compares it with the existing flexibilities, being compulsory licensing.

Ragavan, Srividhya, Waive the IP Rights and Save Lives (November 9, 2021). South Center Publications 2021.

First posted 2021-11-13 12:00:04

Leave a Reply